In a report released on February 10, Michael Siperco from RBC Capital maintained a Hold rating on IAMGOLD (IAG – Research Report), with a price ...
In a report released on February 10, Josh Wolfson from RBC Capital maintained a Buy rating on Sandstorm Gold (SAND – Research Report), with a ...
RBC Capital Markets reiterated their positive stance on Alnylam Pharmaceuticals (NASDAQ:ALNY), maintaining an Outperform rating and a price target of $300.00. According to InvestingPro data, analyst ...
22h
Hosted on MSNRBC Capital Downgrades Pliant Therapeutics (PLRX)Fintel reports that on February 10, 2025, RBC Capital downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) from ...
Find insight on BP in the latest Market Talks covering energy and utilities.
RBC Capital Markets analyst Bish Koziol made eight changes to his quantitatively driven top 40 list of stock picks. Maple ...
RBC Capital raised the firm’s price target on Affirm (AFRM) to $81 from $67 and keeps a Sector Perform rating on the shares. The company delivered a strong quarter with beats across the board and an ...
RBC Capital lowered the firm’s price target on PepsiCo (PEP) to $164 from $172 and keeps a Sector Perform rating on the ...
While Royal Bank focused on dealmaking in the U.S., its biggest domestic rival, TD, embraced retail banking — a 'cutthroat' ...
In this article, we are going to take a look at where International Business Machines Corporation (NYSE:IBM) stands against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results